FHIPO14.MXFHIPO14.MXMEX
Loading
| Metric | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +2.79% | -24.76% | -28.92% | -4.63% | -8.83% |
| Gross Profit Growth | +2.79% | -24.76% | -28.92% | -4.63% | -8.83% |
| EBITDA Growth | -23.45% | -100.00% | -100.00% | -100.00% | -100.00% |
| Operating Income Growth | -23.45% | -35.98% | +0.00% | -33.06% | -66.27% |
| Net Income Growth | -23.52% | -35.82% | -73.82% | -32.65% | -66.99% |
| EPS Growth | -52.50% | -60.00% | -73.58% | -29.73% | -65.79% |
| EPS Diluted Growth | -52.50% | -60.00% | -73.58% | -29.73% | -65.79% |
| Weighted Average Shares Growth | +60.72% | +59.89% | -0.77% | -2.04% | -2.04% |
| Weighted Average Shares Diluted Growth | +60.72% | +59.89% | -0.77% | -2.04% | -2.04% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | -167.98% | +0.00% | +0.00% | +1.55% |
| Free Cash Flow Growth | +0.00% | -168.00% | +0.00% | +0.00% | +0.36% |
| Receivables Growth | -0.00% | +0.63% | -3.56% | -7.93% | -9.54% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -2.84% | -6.33% | -4.55% | +1.38% | -0.82% |
| Book Value per Share Growth | -38.56% | -38.37% | -0.80% | +1.26% | +0.72% |
| Debt Growth | -6.07% | -13.98% | -9.79% | +6.02% | +0.12% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +19.54% | +5.09% | +19.18% | +8.13% | -4.89% |